Evaluation of consumed energy in electrosurgical systems

US11864813B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11864813-B2
Application numberUS-202016874042-A
CountryUS
Kind codeB2
Filing dateMay 14, 2020
Priority dateMay 9, 2019
Publication dateJan 9, 2024
Grant dateJan 9, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.

First claim

Opening claim text (preview).

The invention claimed is: 1. A surgical generator configured to generate and provide a therapeutic signal to biological tissue in electrical communication with a surgical instrument, the surgical generator comprising: a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to: control an energy delivery of the therapeutic signal provided to the biological tissue during at least one of an interrogation phase and a first drying phase, the interrogation phase being to obtain electrical properties of the biological tissue, and the first drying phase being to dry or desiccate the biological tissue; after completion of at least the first drying phase, compare an amount of energy delivered to the biological tissue during the at least one of the interrogation phase and the first drying phase to a threshold energy value; and adjust the delivery of the therapeutic signal based on the comparison and continue delivery of the therapeutic signal, wherein the control circuit configured to adjust delivery of the therapeutic signal based on the comparison is further configured to: control delivery of the energy of the therapeutic signal provided to the biological tissue in order to perform a second drying phase if the amount of energy delivered exceeds the threshold energy value during the at least one of the interrogation phase and the first drying phase, wherein a power ramp rate for the second drying phase is less than a power ramp rate for the first drying phase. 2. The surgical generator of claim 1 , wherein the control circuit is configured to: control an electrical power of the therapeutic signal provided to the biological tissue. 3. The surgical generator of claim 1 , wherein the control circuit is configured to: control a voltage of the therapeutic signal provided to the biological tissue. 4. The surgical generator of claim 1 , wherein the control circuit configured to continue delivery of the therapeutic signal based on the comparison is configured to: control the energy delivery of the therapeutic signal provided to the biological tissue in order to perform a finishing phase to coagulate the biological tissue if the amount of energy delivered is less than the threshold energy value during the at least one of the interrogation phase and the first drying phase. 5. The surgical generator of claim 1 , comprising: a measurement circuit coupled to the control circuit and configured to measure an impedance of the biological tissue; wherein the control circuit is configured to: determine a power ramp rate for delivery of the therapeutic signal based on the measured impedance. 6. The surgical generator of claim 5 , wherein the control circuit is configured to: determine a difference between first and second measured impedances; and adjust the power ramp rate in response to the determined difference being less than a predetermined delta impedance value. 7. The surgical generator of claim 6 , wherein the control circuit configured to adjust the power ramp rate in response to the determined difference being less than the predetermined delta impedance value is configured to: increase the power ramp rate until either the determined difference is equal to or greater than the predetermined delta impedance value or the amount of energy delivered is equal to or greater than the threshold energy value. 8. The surgical generator of claim 1 , comprising: a measurement circuit coupled to the control circuit and configured to measure an impedance of the biological tissue; wherein the control circuit is configured to: during a finishing phase to coagulate the biological tissue: initiate a timer; determine a difference between measured impedances and compare the determined difference to a predetermined delta impedance value; and in response to the determined difference being equal to or greater than the predetermined delta impedance value and the timer being greater than a threshold time limit, generate an error signal. 9. The surgical generator of claim 8 , wherein the error signal is an open circuit error signal. 10. The surgical generator of claim 1 , wherein the control circuit configured to continue delivery of the therapeutic signal based on the comparison is configured to: repeat a drying phase to dry or desiccate the biological tissue. 11. A surgical generator configured to generate and provide a therapeutic signal to biological tissue in electrical communication with a surgical instrument, the surgical generator comprising: a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to: control an energy delivery of the therapeutic signal provided to the biological tissue during at least one of an interrogation phase and a first drying phase, the interrogation phase being to obtain electrical properties of the biological tissue, and the first drying phase being to dry or desiccate the biological tissue; after completion of at least the first drying phase, compare an amount of charge delivered to the biological tissue during the at least one of the interrogation phase and the first drying phase to a charge threshold value; and adjust the delivery of the therapeutic signal based on the comparison and continue delivery of the therapeutic signal, wherein the control circuit configured to adjust delivery of the therapeutic signal based on the comparison is further configured to: control delivery of the energy of the therapeutic signal provided to the biological tissue in order to perform a second drying phase if the amount of charge delivered exceeds the charge threshold value during the at least one of the interrogation phase and the first drying phase, wherein a power ramp rate for the second drying phase is less than a power ramp rate for the first drying phase. 12. The surgical generator of claim 11 , wherein the control circuit configured to continue delivery of the therapeutic signal based on the comparison is configured to: control the energy delivery of the therapeutic signal provided to the biological tissue in order to perform a finishing phase to coagulate the biological tissue if the amount of charge delivered is less than the charge threshold value during the at least one of the interrogation phase and the first drying phase. 13. A method of operating a surgical generator configured to generate and provide a therapeutic signal to biological tissue in electrical communication with a surgical instrument, wherein the surgical generator includes a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the method comprising: controlling an energy delivery of the therapeutic signal provided to the biological tissue during at least one of an interrogation phase and a first drying phase, the interrogation phase being to obtain electrical properties of the biological tissue, and the first drying phase being to dry or desiccate the biological tissue; after completion of at least the first drying phase, comparing an amount of energy delivered to the biological tissue during the at least one of the interrogation phase and the first drying phase to a threshold energy value; and adjusting the delivery of the therapeutic signal based on the comparison and continuing delivery of the therapeuti

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11864813B2 cover?
Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The el…
Who is the assignee on this patent?
Gyrus Acmi Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/1206. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).